Published in Healthcare Mergers, Acquisitions and Ventures Week, May 12th, 2007
The tender offer is conditioned upon at least a majority of the outstanding Biosite shares, determined on a fully diluted basis, being tendered, as well as the satisfaction of other customary conditions. Approval of the transaction by Beckman Coulter's shareholders is not required.
As previously announced, a subsidiary of Beckman Coulter has commenced a cash tender offer to acquire all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.